229 related articles for article (PubMed ID: 25629528)
1. Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.
Ruggiero D; Nappo S; Nutile T; Sorice R; Talotta F; Giorgio E; Bellenguez C; Leutenegger AL; Liguori GL; Ciullo M
PLoS Genet; 2015 Jan; 11(1):e1004976. PubMed ID: 25629528
[TBL] [Abstract][Full Text] [Related]
2. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
[TBL] [Abstract][Full Text] [Related]
3. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
[TBL] [Abstract][Full Text] [Related]
4. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract][Full Text] [Related]
5. Cripto-1: an embryonic gene that promotes tumorigenesis.
de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
[TBL] [Abstract][Full Text] [Related]
6. Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression.
Pilli VS; Gupta K; Kotha BP; Aradhyam GK
FEBS Lett; 2015 May; 589(11):1249-56. PubMed ID: 25889638
[TBL] [Abstract][Full Text] [Related]
7. Cripto monoclonal antibodies.
Hu XF; Xing PX
Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
[TBL] [Abstract][Full Text] [Related]
8. An evolving web of signaling networks regulated by Cripto-1.
Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
[TBL] [Abstract][Full Text] [Related]
9. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
[TBL] [Abstract][Full Text] [Related]
10. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
[TBL] [Abstract][Full Text] [Related]
11. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
[TBL] [Abstract][Full Text] [Related]
12. CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
Terry S; El-Sayed IY; Destouches D; Maillé P; Nicolaiew N; Ploussard G; Semprez F; Pimpie C; Beltran H; Londono-Vallejo A; Allory Y; de la Taille A; Salomon DS; Vacherot F
Oncotarget; 2015 May; 6(14):11994-2008. PubMed ID: 25596738
[TBL] [Abstract][Full Text] [Related]
13. Cripto: a tumor growth factor and more.
Adamson ED; Minchiotti G; Salomon DS
J Cell Physiol; 2002 Mar; 190(3):267-78. PubMed ID: 11857442
[TBL] [Abstract][Full Text] [Related]
14. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
15. The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.
Park SW; Do HJ; Han MH; Choi W; Kim JH
FEBS Lett; 2018 Jan; 592(1):24-35. PubMed ID: 29223130
[TBL] [Abstract][Full Text] [Related]
16. Role of the EGF-CFC gene cripto in cell differentiation and embryo development.
Minchiotti G; Parisi S; Liguori GL; D'Andrea D; Persico MG
Gene; 2002 Apr; 287(1-2):33-7. PubMed ID: 11992720
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
18. miR-3929 Inhibits Proliferation and Promotes Apoptosis by Downregulating Cripto-1 Expression in Cervical Cancer Cells.
Wang Y; Li X; Wang S; Song Z; Bao Y; Zheng L; Wang G; Sun Y
Cytogenet Genome Res; 2021; 161(8-9):425-436. PubMed ID: 34569498
[TBL] [Abstract][Full Text] [Related]
19. The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer.
Sato J; Karasawa H; Suzuki T; Nakayama S; Katagiri M; Maeda S; Ohnuma S; Motoi F; Naitoh T; Unno M
Cancer Invest; 2020 Apr; 38(4):214-227. PubMed ID: 32157913
[TBL] [Abstract][Full Text] [Related]
20. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
Zoni E; Chen L; Karkampouna S; Granchi Z; Verhoef EI; La Manna F; Kelber J; Pelger RCM; Henry MD; Snaar-Jagalska E; van Leenders GJLH; Beimers L; Kloen P; Gray PC; van der Pluijm G; Kruithof-de Julio M
Oncogene; 2017 Aug; 36(33):4739-4749. PubMed ID: 28394345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
